Report - Mallinckrodt Pharmaceuticals: Discussion Materials · 2021. 1. 20. · Amitiza 9% Other 1% _____ (1) 2019 net sales excluding BioVectra. (2) Active Pharmaceutical Ingredients. (3)

Please pass captcha verification before submit form